TOP TIERMARKET NEWSWIRE
News & sentiment

AEON BIOPHARMA INC A (AEON) — News & AI sentiment

AEON BIOPHARMA INC A (AEON) news roundup. 6 stories aggregated over the last 30 days. Average 30-day sentiment is 52.2/100. Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $243K and 0 sales totalling $0 — net buying of $243K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
6
avg sentiment 52.2/100
Insider net (90d)
$243K
1 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

AEON news in the last 24 hours, 7 days, 30 days and 90 days

How much AEON coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAEON storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days652.2/100AEON headlines →
Last 90 days3452.4/100AEON headlines →

Latest stories on AEON

Oct 23
AEON Biopharma, Inc. (AEON) files 8-K
SEC 8-K50 · neutralgeneral
Oct 23
Oct 9
Oct 9
Oct 9
Oct 1
Sep 30
Sep 30
Sep 30
AEON Biopharma, Inc. (AEON) files 8-K
SEC 8-K50 · neutralgeneral
Sep 30
Sep 30
Sep 30
Sep 17
Sep 9
Sep 9
Sep 9
Sep 9
Laidlaw initiates Aeon Biopharma stock coverage with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Sep 9
Aug 31
Aug 31
Aug 25
Aug 24
Aug 24
Aug 19
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution
Investing.com Analyst Ratings32 · bearishanalyst
Aug 17
Open AEON in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →